Both ADAMTS and MMP family members are known to be BMI1 targets in GIC and NPC, as assessed by ChIP Seq (79), and their predicted upstream regulator, MYC, has also been described to be controlled by BMI1 in prostate cancer (103). Here, BMI1 is linked to prostate carcinoma.